MINI FUTURE LONG - NOVO-NORDISK B Stock

Certificat

JG9LB

NLBNPNL2H9F0

Market Closed - Euronext Paris 12:30:02 2024-06-11 pm EDT
12.3 EUR -1.83% Intraday chart for MINI FUTURE LONG - NOVO-NORDISK B
Current month+14.68%
1 month+27.45%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-11 12.3 -1.83%
24-06-10 12.54 +1.21%
24-06-07 12.38 +2.40%
24-06-06 12.1 +8.38%
24-06-04 11.16 +3.43%

Real-time Euronext Paris

Last update June 11, 2024 at 12:30 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
JG9LB
ISINNLBNPNL2H9F0
Date issued 2023-08-24
Strike 528.8 kr
Maturity Unlimited
Parity 5 : 1
Emission price 3.63
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.63
Lowest since issue 2.92

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
982 DKK
Average target price
929.5 DKK
Spread / Average Target
-5.35%
Consensus
  1. Stock Market
  2. Certificates
  3. JG9LB Certificat